This section is not available in the published analysis.
NeogenTC: Audience
NeogenTC is a biotechnology company focused on developing innovative cancer immune T cell therapies. Their primary product utilizes tumor-infiltrating lymphocytes (TILs) to effectively target and treat solid tumors.